Resources for Researchers & Startups

COVID-19 technology?

Our online portal is open and ready.
Disclose now

We have seen our inventors and entrepreneurs rise to the challenges brought by COVID-19 this past year, and we are thankful and proud of each one of you. We at UF Innovate are here to facilitate your efforts as you continue to invent, create entrepreneurial solutions, and do all you can to change the world for the better. We hope this page of resources and stories about how UF Innovate research and entrepreneurs are doing their part to help in this pandemic encourages and inspires you.

Contact us.


Apply Here

illustration of money

Small business owners can apply for a First Draw Loan from the Payroll Protection Program by the U.S. Small Business Administration. Applications still open.


Grants & Funding

image of the coronavirus, COVID-19

Looking for program development and funding opportunities during COVID-19? Visit UF’s Emerging Pathogen’s Funding webpage to learn about available grants.


Latest UF Research

two beakers depicting research

UF researchers continue to respond to the COVID-19 crisis by doing what they do best — finding answers and solutions. Read the latest research here.


Loan Guidelines

flag of the United States of America

The U.S. Chamber of Commerce continues to help companies stay afloat and keep paychecks flowing and more. Details on relief package and vaccines here.


CORD-19 Dataset

Help generate new insights to fight COVID-19, collaborate with other researchers worldwide, participate in the CORD-19 Challenge. Learn more.


UF Health Facts

Get the fast facts about UF Health’s responses and learn about the work our researchers conduct to combat the global pandemic. The latest here.


Startup Advice

logo for Osage University Partners, a venture capital firmDo you have an idea for a startup? OUP’s tech and life sciences teams are offering free VC office hours to UF researchers. Sign up for a 30-minute complimentary session.


Funding Innovation

illustration of a microscope

The Bill & Melinda Gates Foundation pledges millions to fund innovation that tackles COVID-19 challenges. Get the latest here.


Impact on Research

logo for University of Florida Research

The coronavirus is a challenge impacting researchers at the university. UF Research is doing its best to keep researchers updated. More here.

UF Innovate Tech & Startups Aid the Fight

What You Need to Know About the Possible Smell/Taste Link to COVID-19

As more anecdotes surface from physicians around the world about patients with COVID-19 losing their senses of smell and taste, we asked Steven Munger, Ph.D., director of the University of Florida Center for Smell and Taste, located within UF’s McKnight Brain Institute, what science can tell us about the potential...
Read More

DiaCarta SARS-CoV-2 Test Kit Receives CE Mark

Molecular diagnostic firm and UF Innovate | Sid Martin Biotech alum DiaCarta said that its QuantiVirus SARS-CoV-2 test recently received the CE mark. The firm has also filed for Emergency Use Authorization of the test with the US Food and Drug Administration. The company’s qRT-PCR test detects viral RNA extracted...
Read More

COVID-19 Expert Nursing Panel Q & A

UF startup Shadow Health, an educational technology company, facilitated a panel discussion and Q & A with the Global Nursing Education Virtual Simulation Consortium on the topic of Clinical Hour Replacement in the Face of the COVID-19 Pandemic. Learn more about COVID-19 Expert Nursing Panel Q & A.

Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense

The Department of Defense (DOD) awarded a contract valued at $14 million with UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus. This work...
Read More

Algernon Appoints Novotech As CRO for Phase 2 Coronavirus Ifenprodil Trial

UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it has chosen to appoint award winning Novotech as the contract research organization (CRO) for a planned physician initiated study of NP-120 (Ifenprodil) for COVID-19 infected patients in South Korea. Novotech is an internationally recognized full service CRO...
Read More

Algernon Announces Filing of U.S. FDA Pre-Ind Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use

UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it has filed its pre-IND (Investigational New Drug) meeting request with the U.S. FDA. This initiates formal communications with the U.S. FDA regarding the development of the company’s repurposed drug NP-120 (Ifenprodil) for the treatment and prevention of...
Read More